(Finance) – Reduction for Walgreens Boots Alliancewhich trades at a loss of 12.74% on previous values.
The U.S. Department of Justice accused the pharmacy chain of contributing to the opioid crisis by dispensing millions of illegal, medically unjustified prescriptions in violation of the Controlled Substances Act and the False Claims Act.
The one-week trend of distributor of pharmaceutical products is more sluggish compared to the trend of Nasdaq 100. This decline could trigger opportunities for the market to sell the stock.
The technical status of Walgreens Boots Alliance is strengthening in the short term, with resistance area seen at USD 11.52, while the first support is estimated at 10.55. The technical implications favor an expansion of performance in a bullish direction, with resistance seen at 12.48.